. Anticonvulsant-Induced Rickets. OrthopaedicsOne Cases. In: OrthopaedicsOne - The Orthopaedic Knowledge Network. Created Sep 14, 2011 11:53. Last modified Jul 18, 2012 09:10 ver.7. Retrieved 2019-04-25, from https://www.orthopaedicsone.com/x/DYIQB.
Case: Anticonvulsant-Induced Rickets
Reported by Andrew Porter
L.D., a 14 year old male with severe mental retardation and epilepsy, was referred for consideration of scoliosis.
The curve was found to be minimal but examination showed deformity of the right wrist. Xray revealed features diagnositic of rickets. An Xray of his left wrist taken 5 years previously was normal. A history of medication with phenytoin and phenobarbitone was elicited from his care-givers. He was placed on vitamin D supplementation.
On follow up, the rachitic changes in his wrist have significantly improved.
Left wrist, 1994
Right wrist, March 1999
Right wrist, June 1999
Right wrist, October 1999
FROM: Myles Clough
As an orthopaedic surgeon, I thought that this case was extremely rare as we come across this type of problem so infrequently. However, reviewing the literature for this site suggested a very different picture. High incidences of rickets (around 4%) were reported in institutionalized epileptic children and numerous studies suggested that abnormalities of vitamin D metabolism are present throughout that population. Increased risk factors appear to include non-ambulatory status, poor diet and lack of exposure to sunlight - all presumably correlated with the severity of mental retardation. Various papers suggest that vit D supplements should be routinely offered to the population of mentally retarded, epileptic, poorly ambulant children. Osteomalacia in the older institutionalized epileptic patient is also common.
There is little in the orthopaedic literature but a study by Lee et al in Detroit shows that pathological fractures in this population are common. They suggest that vitamin D levels should be measured in all such children with fractures and that non-accidental injury should be ruled out where the vitamin D level is normal!
Francis RM, et al. Osteomalacia. Baillieres Clin Endocrinol Metab. 1997 Apr;11(1):145-63. Review.
Baer MT, et al. Vitamin D, calcium, and bone status in children with developmental delay in relation to anticonvulsant use and ambulatory status. Am J Clin Nutr. 1997 Apr;65(4):1042-51
Henderson RC. Vitamin D levels in noninstitutionalized children with cerebral palsy. J Child Neurol. 1997 Oct;12(7):443-7.
Alderman CP, et al. Abnormal bone mineral metabolism after long-term anticonvulsant treatment. Ann Pharmacother. 1994 Jan;28(1):47-8.
Tomita S, et al. The effects of anticonvulsant drugs on vitamin D3-activating cytochrome P-450-linked monooxygenase systems. J Steroid Biochem Mol Biol. 1991 Oct;39(4A):479-85.
Lluch Fernandez MD, et al. Phosphorus-calcium metabolism in children under long-term anticonvulsant therapy. An Esp Pediatr. 1991 Aug;35(2):103-7. Review. Spanish.
Lamberg-Allardt C, et al. Vitamin D status of ambulatory and nonambulatory mentally retarded children with and without carbamazepine treatment. Ann Nutr Metab. 1990;34(4):216-20.
Lee JJ, et al. Pathologic fractures in severely handicapped children and young adults. J Pediatr Orthop. 1990 Jul-Aug;10(4):497-500.
Lee JJ, et al. Disorders of bone metabolism in severely handicapped children and young adults. Clin Orthop. 1989 Aug;(245):297-302.
Hartwell D, et al. Metabolism of vitamin D2 and vitamin D3 in patients on anticonvulsant therapy. Acta Neurol Scand. 1989 Jun;79(6):487-92.
Riancho JA, et al. Influence of solar irradiation on vitamin D levels in children on anticonvulsant drugs. Acta Neurol Scand. 1989 Apr;79(4):296-9.
Zeiss J, et al. Radiological case of the month. Simulated child abuse in drug-induced rickets. Am J Dis Child. 1988 Dec;142(12):1367-8.
Fischer MH, et al. Bone status in nonambulant, epileptic, institutionalized youth. Improvement with vitamin D therapy. Clin Pediatr (Phila). 1988 Oct;27(10):499-505.
Robinson PB, et al. Inhibition of cartilage growth by the anticonvulsant drugs diphenylhydantoin and sodium valproate. Br J Exp Pathol. 1988 Feb;69(1):17-22.
Schonau E, et al. Significance and selected examples for using determinations of isoenzyme of alkaline phosphatase in pediatrics. Monatsschr Kinderheilkd. 1987 Sep;135(9):637-41. German.
Ala-Houhala M, et al. Long-term anticonvulsant therapy and vitamin D metabolism in ambulatory pubertal children. Neuropediatrics. 1986 Nov;17(4):212-6.
Hunt PA, et al. Bone disease induced by anticonvulsant therapy and treatment with calcitriol (1,25-dihydroxyvitamin D3). Am J Dis Child. 1986 Jul;140(7):715-8.
Nishiyama S, et al. Decreased bone density in severely handicapped children and adults, with reference to the influence of limited mobility and anticonvulsant medication. Eur J Pediatr. 1986 Feb;144(5):457-63.
Arico M, et al. Radiological aspects of a case of rickets during therapy with anticonvulsant agents. Radiol Med (Torino). 1984 Dec;70(12):996-8. Italian.
Williams C, et al. Vitamin D metabolism and anticonvulsant therapy: effect of sunshine on incidence of osteomalacia. South Med J. 1984 Jul;77(7):834-6, 842.
Schmitt BP, et al. Prevalence of hypocalcemia and elevated serum alkaline phosphatase in patients receiving chronic anticonvulsant therapy. J Fam Pract. 1984 Jun;18(6):873-7.
Moskowitz H, et al. Case report 285. Diagnosis: osteomalacia (rickets) and cerebellar atrophy secondary to the effects of diphenylhydantoin (dilantin). Skeletal Radiol. 1984;12(4):281-3.
Davie MW, et al. Low plasma 25-hydroxyvitamin D and serum calcium levels in institutionalized epileptic subjects: associated risk factors, consequences and response to treatment with vitamin D. Q J Med. 1983 Winter;52(205):79-91.
Tezic T, et al. Phenytoin-induced rickets in a ten-year-old girl with hypothyroidism. Turk J Pediatr. 1983 Oct-Dec;25(4):263-6.
Stogmann W. Disorders of calcium metabolism and ossification caused by anticonvulsants. Padiatr Padol. 1983;18(2):119-21. German.
Hahn TJ, et al. Serum dihydroxyvitamin D metabolite concentrations in patients on chronic anticonvulsant drug therapy: response to pharmacologic doses of vitamin D2. Metab Bone Dis Relat Res. 1983-84;5(1):1-6.
Bianchini G, et al. Calcium-phosphorus changes in chronic anticonvulsant therapy: effects of the administration of 25-hydroxyvitamin D3 on secondary hyperparathyroidism. Acta Vitaminol Enzymol. 1983;5(4):229-34. Italian.
Christiansen C, et al. Pathophysiology behind anticonvulsant osteomalacia. Acta Neurol Scand Suppl. 1983;94:21-8.
Fedorova EV, et al. Rachitis and rachitis-like changes in children receiving anticonvulsant therapy. Pediatriia. 1982 Jul;(7):36-8. Russian.
Hoikka V, et al. Anticonvulsant osteomalacia in epileptic outpatients. Ann Clin Res. 1982 Jun;14(3):129-32.
Tebloeva LT, et al. Rickets in children induced by anticonvulsant therapy. Pediatriia. 1982 Jun;(6):75-7. Review. Russian.
Hoikka V, et al. Treatment of osteomalacia in institutionalized epileptic patients on long-term anticonvulsant therapy. Ann Clin Res. 1982 Apr;14(2):72-5.
Kruse K, et al. Response of kidney and bone to parathyroid hormone in children receiving anticonvulsant drugs. Neuropediatrics. 1982 Feb;13(1):3-9.
Ishitsu T, et al. Anticonvulsant-induced rickets associated with renal tubular acidosis and normal level of serum 1,25-dihydroxyvitamin D. Am J Dis Child. 1981 Dec;135(12):1140-2.
Sebes JI, et al. Rickets due to chronic anticonvulsant therapy. IMJ Ill Med J. 1981 Jul;160(1):28-30.
Morijiri Y, et al. Factors causing rickets in institutionalised handicapped children on anticonvulsant therapy. Arch Dis Child. 1981 Jun;56(6):446-9.
Juan D. Vitamin D metabolism: update for the clinician. Postgrad Med. 1980 Nov;68(5):210-4, 217-8.
McCrea ES, et al. Roentgenographic changes during long-term diphenylhydantoin therapy. South Med J. 1980 Mar;73(3):312-7.
Weisman Y, et al. Decreased serum 24,25-dihydroxy vitamin D concentrations in children receiving chronic anticonvulsant therapy. Br Med J. 1979 Sep 1;2(6189):521-3.
Matsuda I, et al. Pseudohypoparathyroidism type II and anticonvulsant rickets. Eur J Pediatr. 1979;132(4):303-8.
Villareale ME, et al. Bone changes induced by diphenylhydantoin in chicks on a controlled vitamin D intake. J Bone Joint Surg Am. 1978 Oct;60(7):911-6.
Kruse K, et al. Serum alkaline phosphatase isoenzymes in epileptic children receving anticonvulsant drugs. Eur J Pediatr. 1977 Nov 4;126(4):237-42.
Sherk HH, et al. Vitamin D prophylaxis and the lowered incidence of fractures in anticonvulsant rickets and osteomalacia. Clin Orthop. 1977 Nov-Dec;(129):251-7.
Vose GP, et al. Skeletal status in mentally retarded patients on anticonvulsive therapy. Growth. 1977 Sep;41(3):161-9.
Winnacker JL, et al. Rickets in children receiving anticonvulsant drugs. Biochemical and hormonal markers. Am J Dis Child. 1977 Mar;131(3):286-90.
Addy DP. Rickets associated with anticonvulsant therapy in children with tuberous sclerosis. Arch Dis Child. 1976 Dec;51(12):972-4.
Baleva R, et al. Bone metabolic disorders after prolonged treatment with antiepileptic agents in a patient with idiopathic hypoparathyroidism. Vutr Boles. 1976;15(5):93-7. Bulgarian.
Berger G, et al. Pathogenesis of osteopathy caused by anticonvulsives. Padiatr Padol. 1976;11(3):528-38. German
Hahn TJ. Bone complications of anticonvulsants. Drugs. 1976;12(3):201-11. Review.
Wendenburg HH, et al. Vitamin D deficiency. Osteopathy after prolonged treatment with anticonvulsents. ROFO Fortschr Geb Rontgenstr Nuklearmed. 1976 Jan;124(1):7-11. German.
Liakakos D, et al. Serum alkaline phosphatase and urinary hydroxyproline values in children receiving phenobarbital with and without vitamin D. J Pediatr. 1975 Aug;87(2):291-6.
Crosley CJ, et al. Rickets associated with long-term anticonvulsant therapy in a pediatric outpatient population. Pediatrics. 1975 Jul;56(1):52-7.
No authors listed. Anticonvulsant osteomalacia. Arch Intern Med. 1975 Jul;135(7):997-1000.
Dent CE. Rickets and osteomalacia of various origins. Birth Defects Orig Artic Ser. 1971 May;7(6):79-85.